Study on mHealth Smoking Cessation for African Americans with HIV/AIDS Initiated
A study is underway to evaluate an mHealth intervention for smoking cessation among Black individuals with HIV/AIDS.
Phase III
Pulmonology / Smoking Cessation
Status
Initiated
Signal Score
8.2
Signal assessment
Signal strength
high
Confidence level
moderate
Why it matters
This trial focuses on a targeted smoking cessation intervention for African Americans with HIV/AIDS, a demographic that has historically faced health disparities. The outcomes could inform future product development and marketing strategies for smoking cessation therapies aimed at underserved populations.
Recommended action
Humanexa recommends Monitor.
Analysis
Monitor enrollment numbers and preliminary results from the trial to gauge efficacy and potential market impact.
Related companies & assets
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.